11 C ‐Hydroxyephedrine PET / CT for preoperative surgical planning in large pheochromocytoma and paraganglioma
Journal of Neuroendocrinology · 2026
DOI: 10.1111/jne.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, 2026. Verfasst von Achyut Ram Vyakaranam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences-Molecular Imaging and Medical Physics, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Paraganglioma, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Early detection of metastases and timely surgical intervention play a crucial role in the management of neuroendocrine tumors. In large‐sized pheochromocytomas and sympathetic paragangliomas (PPGL), functional imaging with positron emission tomography (PET) is recommended, as it improves the detection of metastases, which may go undetected on conventional radiologic imaging. 11 C‐hydroxyephedrine binds to the norepinephrine transporter receptor and is detected by PET/CT (HED‐PET/CT). It has previously demonstrated high accuracy in detecting primary and metastatic PPGL; however, its impact on preoperative staging is unclear. In this study, we retrospectively analyzed a selected cohort of 44 patients with large PPGL to evaluate whether HED‐PET/CT influences preoperative clinical decision‐making. All patients who underwent HED ‐ PET / CT at Uppsala University Hospital between 2004 and 2024 were screened for inclusion. In total, 44 patients with pheochromocytomas >5 cm and paragangliomas >4 cm were included. HED ‐ PET / CT results were compared with CT / MR findings, and a final consensus was reached on whether preoperative HED ‐ PET / CT would have altered clinical decision‐making. HED‐PET/CT identified previously undetected metastatic disease in three patients (6.8%), which had not been visualized on CT/MR. Additionally, two patients had discordant findings, where HED‐PET/CT revealed additional metastases. In one case, a liver metastasis was identified postoperatively with HED‐PET/CT, leading to a metastasectomy that could have potentially been avoided. These findings suggest that HED‐PET/CT is highly accurate in detecting metastases; however, its routine preoperative use may be limited and appears to provide significant clinical benefit only in selected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Sciences-Molecular Imaging and Medical Physics, Uppsala University, Uppsala, Sweden.
- Department of Surgical Sciences-Endocrine Surgery, Uppsala University, Uppsala, Sweden.
- Department of Medical Sciences-Endocrine Tumour Biology, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Tobias Åkerström
Zitieren
APA
Vyakaranam, A. R., Norlén, O., Akural, A., Crona, J., Annebäck, M., Klimàcek, B., Stålberg, P., Sundin, A., & Åkerström, T. (2026). 11 C ‐Hydroxyephedrine PET / CT for preoperative surgical planning in large pheochromocytoma and paraganglioma. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.70121
Vancouver
Vyakaranam AR, Norlén O, Akural A, Crona J, Annebäck M, Klimàcek B, et al. 11 C ‐Hydroxyephedrine PET / CT for preoperative surgical planning in large pheochromocytoma and paraganglioma. Journal of Neuroendocrinology. 2026. doi:10.1111/jne.70121
BibTeX
@article{Vyakaranam2026,
author = {Vyakaranam, Achyut Ram and Norlén, Olov and Akural, Alina and Crona, Joakim and Annebäck, Matilda and Klimàcek, Branislav and Stålberg, Peter and Sundin, Anders and Åkerström, Tobias},
title = {11 C ‐Hydroxyephedrine PET / CT for preoperative surgical planning in large pheochromocytoma and paraganglioma},
journal = {Journal of Neuroendocrinology},
year = {2026},
doi = {10.1111/jne.70121}
}
EUVIMED